Dr. Xu Huji
徐沪济
Hospital
Changzheng Hospital, Naval Medical University (Second Military Medical University), Shanghai
Experience
30+ years in rheumatology and immunology
Languages
English, Mandarin
Chief Physician; Professor; Director of Rheumatology and Immunology Department
Pioneered the clinical application of CAR-T cell therapy for refractory autoimmune diseases in China, with groundbreaking results in patients with treatment-resistant lupus and inflammatory myopathy; established one of China's largest ankylosing spondylitis cohorts; led clinical trials on novel biologic agents for spondyloarthritis; served on multiple Chinese and international rheumatology expert committees; published in Nature Medicine, Annals of the Rheumatic Diseases, and Signal Transduction and Targeted Therapy
Dr. Xu is a top choice for patients with severe ankylosing spondylitis or those interested in cutting-edge cellular therapy approaches for refractory autoimmune conditions. His team at Changzheng Hospital is among the first in the world to offer CAR-T therapy for autoimmune diseases in a clinical setting.
Research this doctor's background on trusted platforms.
Results are automated searches and may include other individuals with similar names.
Information is provided for reference only and may not reflect current conditions. Please verify directly with the hospital before making decisions.